Oxford Asset Management »

Cabaletta Bio shares owned by Oxford Asset Management

Quarter-by-quarter ownership of Cabaletta Bio (CABA) shares owned by Oxford Asset Management from 13F filings

Historical chart of Oxford Asset Management investment in Cabaletta Bio

Tip: Access up to 7 years of quarterly data

All positions including Cabaletta Bio held by Oxford Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cabaletta Bio by Oxford Asset Management

Quarter filed Position value Share count Share price at filing
2025-03-31 $21k 15k 1.39

More positions owned by Oxford Asset Management

Spdr Series Trust S&p Biotech (XBI)
Snap Note 0.125% 3/0
Freeport-mcmoran CL B (FCX)
Dropbox Note 3/0
General Mills (GIS)
Ford Motor Company (F)
Comcast Corp Cl A (CMCSA)
Citigroup Com New (C)
Ferguson Enterprises Common Stock New (FERG)
Nike CL B (NKE)
Amazon (AMZN)
Boeing Company (BA)
EOG Resources (EOG)
Pfizer (PFE)
Meridianlink Common Stock (MLNK)

View all positions for Oxford Asset Management

Top funds holding Cabaletta Bio

Bain Capital Life Sciences Investors
Adage Capital Partners GP
Jennison Associates
T. Rowe Price Investment Management
Cormorant Asset Management
Vanguard Group
Woodline Partners
Heights Capital Management
BlackRock
Superstring Capital Management
Renaissance Technologies
Marshall Wace
Alyeska Investment Group
Schonfeld Strategic Advisors
Citadel Advisors

View all funds holding Cabaletta Bio